iSpecimen (NASDAQ:ISPC) Releases Quarterly Earnings Results

iSpecimen (NASDAQ:ISPC) posted its earnings results on Monday. The company reported ($6.28) earnings per share (EPS) for the quarter, Zacks reports. iSpecimen had a negative net margin of 91.66% and a negative return on equity of 139.25%.

iSpecimen Stock Up 4.1 %

Shares of ISPC stock traded up $0.05 during trading hours on Monday, hitting $1.27. 18,724 shares of the company’s stock traded hands, compared to its average volume of 420,018. The stock has a market cap of $1.22 million, a price-to-earnings ratio of -0.07 and a beta of 1.77. The stock’s fifty day simple moving average is $1.53 and its two-hundred day simple moving average is $2.94. iSpecimen has a 12-month low of $1.02 and a 12-month high of $11.80.

iSpecimen Company Profile

iSpecimen Inc provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide. Its cloud-based technology enables scientists to search for specimens and patients across a network of hospitals, clinics, private practice groups, laboratories, blood centers, biobanks, clinical research sites, and cadaveric donation centers.